1. Home
  2. ZUMZ vs SLGL Comparison

ZUMZ vs SLGL Comparison

Compare ZUMZ & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zumiez Inc.

ZUMZ

Zumiez Inc.

HOLD

Current Price

$18.18

Market Cap

307.1M

ML Signal

HOLD

Logo Sol-Gel Technologies Ltd.

SLGL

Sol-Gel Technologies Ltd.

SELL

Current Price

$80.00

Market Cap

276.9M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ZUMZ
SLGL
Founded
1978
1997
Country
United States
Israel
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
307.1M
276.9M
IPO Year
2005
2016

Fundamental Metrics

Financial Performance
Metric
ZUMZ
SLGL
Price
$18.18
$80.00
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$18.00
$110.00
AVG Volume (30 Days)
229.8K
41.1K
Earning Date
06-04-2026
05-22-2026
Dividend Yield
N/A
N/A
EPS Growth
966.67
N/A
EPS
N/A
N/A
Revenue
$929,057,000.00
N/A
Revenue This Year
$4.30
N/A
Revenue Next Year
$3.30
$223.84
P/E Ratio
N/A
N/A
Revenue Growth
4.48
N/A
52 Week Low
$15.00
$20.06
52 Week High
$31.70
$97.97

Technical Indicators

Market Signals
Indicator
ZUMZ
SLGL
Relative Strength Index (RSI) 44.14 48.57
Support Level $17.00 $67.89
Resistance Level $19.16 $81.18
Average True Range (ATR) 0.64 6.41
MACD -0.18 -0.77
Stochastic Oscillator 28.74 44.24

Price Performance

Historical Comparison
ZUMZ
SLGL

About ZUMZ Zumiez Inc.

Zumiez Inc is a United States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art, action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.

Share on Social Networks: